All variables in this study were available on a public repository website (<https://github.com/kuochuanwu/SNPbarcode>) and my minimal data (filename: 190618 CYP26 SNPs-environment_risk.xlsx) set as the supplementary data, [S1 Table](#pone.0220719.s001){ref-type="supplementary-material"}.

Introduction {#sec005}
============

Oral malignant disorders include cancers of the oral cavity and pharynx and oral potentially malignant disorders (OPMD), such as leukoplakia, oral submucous fibrosis (OSF), verrucous hyperplasia, and erythroplakia \[[@pone.0220719.ref001]\]. In the world, oral and pharyngeal cancers is the sixth most prevalent cancer \[[@pone.0220719.ref002]\], and patients with OPMD may experience malignant transformation into oral and pharyngeal cancers \[[@pone.0220719.ref003]--[@pone.0220719.ref006]\].

Environmental carcinogens and genetic polymorphisms (single-nucleotide polymorphisms (SNPs)) are essential components in oral malignant disorder expression. Alcohol consumption, betel quid (BQ) use, and cigarette consumption are significantly related to the risk of developing oral malignant disorders, and a joint effect has been observed when several of these factors are expressed simultaneously \[[@pone.0220719.ref007]--[@pone.0220719.ref010]\]. Previous studies have demonstrated that environmental and genetic factors are associated in the carcinogenesis of malignant disorders \[[@pone.0220719.ref011], [@pone.0220719.ref012]\]. For example, some oral cancer studies have demonstrated that phase I cytochrome P450 (*CYP*) enzymes may be associated with the metabolic activation of environmental carcinogens \[[@pone.0220719.ref010], [@pone.0220719.ref013]--[@pone.0220719.ref016]\].

In the human genome, SNPs are the most common sequence variations \[[@pone.0220719.ref017]\]. SNPs are widely used as suitable markers in association studies of several diseases \[[@pone.0220719.ref018]\], cancers \[[@pone.0220719.ref019]\], and in pharmacogenomics \[[@pone.0220719.ref020]\]. Recently, studies have suggested that SNPs of *CYP26* family genes, such as *CYP26A1*, *CYP26B1*, and *CYP26C1*, were associated with susceptibility to oral and pharyngeal cancers \[[@pone.0220719.ref021], [@pone.0220719.ref022]\]. Although genes encoding *CYP* enzymes and environmental factors have been separately evaluated for their effects on the risk of developing oral malignant disorders in previous studies, the combined effect of these genes and environmental factors requires further investigation.

Our previous studies have illustrated that evolutionary algorithms (such as binary particle swarm optimization (BPSO) with an odds ratio (OR)-based method and genetic algorithm) can be used to analyze the associations of multiple SNPs \[[@pone.0220719.ref023]--[@pone.0220719.ref028]\]. Evolutionary algorithms have been used to combine SNPs with genotypes, namely SNP barcodes, e.g. GG, GT, and TT for a SNP with G/T polymorphism \[[@pone.0220719.ref023]--[@pone.0220719.ref028]\]. These SNPs are aligned with environmental factors, which provide the maximal risk difference of occurrence between the case and control groups and can forecast the susceptibility of the risks of oral diseases (e.g., oral malignant disorders) \[[@pone.0220719.ref023], [@pone.0220719.ref024]\]. Indeed, we refer to these associations as "SNP-environment barcodes," which can be used to predict the risks of disease. Our method is based on the concept of simulation barcoding to evaluate the risks of oral malignant disorders using SNP-environment combinations \[[@pone.0220719.ref023]--[@pone.0220719.ref028]\].

Moreover, BPSO of the OR-based method can decide the best SNP-environment barcodes without computing each combination separately and can present the optimal SNP-environment barcodes, which are regarded as a new quantitative measure with maximal statistical difference between case and control groups \[[@pone.0220719.ref027]\]. This study aimed to apply a powerful OR-based BPSO method to solve the issue related to the simultaneous analysis of multiple independent SNPs and environmental factors that are associated with oral malignant disorders.

Material and methods {#sec006}
====================

Participants and data collection {#sec007}
--------------------------------

A case-control study (N = 576) was conducted to analyze the risk of occurrence of oral malignant disorders. This study included oral and pharyngeal cancers (n = 242), OPMD (n = 70), and health controls with high prevalence of BQ chewing (n = 264). We identified polymorphisms of *CYP26* family genes by searching the SNP database and conducted a hospital-based case-control study to verify these SNP variants and environmental factors are associated with oral malignant disorders. Data from male patients diagnosed with oral/pharyngeal cancers were collected from the Kaohsiung Medical University Hospital in Taiwan. Based on an oral health survey, healthy male subjects were recruited to comprise a control group from a community with high prevalence of BQ chewing. Written informed consent were signed for all subjects and voluntarily provided whole blood samples. This study was approved and ascertained by the Institutional Review Board of Kaohsiung Medical University Hospital (KMUH-IRB-950315 and KMUH-IRB-20110031). Ethnic categories were classified as Minnan, Hakka, and Taiwanese aborigines. Education levels were classified as ≤6 and \>6 years of education. Data pertaining to substance use status, including alcohol drinking, BQ chewing, and cigarette use, and demographic characteristics were collected by professionally trained interviewers. An alcohol drinker was defined as someone who drank alcoholic beverages (regardless of volume) at least once per week for more than 1 year, BQ chewers were defined as those who chewed at least one quid per day for more than a year, and cigarette smokers were defined as those who smoked at least 10 cigarettes per week for more than 1 year.

SNP-SNP association problem {#sec008}
---------------------------

An OR is one of the main tools for quantifying the association between exposure and outcome in a given population. Furthermore, OR is most commonly applied in case-control studies to assess the combination of risk factors. In this study, the OR was estimated as follows: $$OR = \frac{D_{E} \times H_{N}}{H_{E} \times D_{N}}$$ where *D*~*E*~ is the number of exposed individuals with disease, *H*~*N*~ is number of healthy individuals who were not exposed, *H*~*E*~ is number of healthy individuals who were exposed, and *D*~*N*~ is the number of individuals with a disease who were not exposed. The Pearson chi-square statistic is used to identify factor × factor interaction, which in turn was used to assess significance (*p* \< 0.05) in this study. This model measures the interaction between factors (SNPs or environmental factors) and status (genotype or situation) in a two-way contingency table. The estimation value of the test-statistic is shown below: $$\chi = {\sum\frac{\left( observed - expected \right)^{2}}{expected}}$$

Binary particle swarm optimization (BPSO) {#sec009}
-----------------------------------------

BPSO \[[@pone.0220719.ref029], [@pone.0220719.ref030]\] is a swarm intelligence-based optimizer inspired by the social behaviors of birds in finding food. In this method, a particle simulates a bird seeking the best solution in an established space for a particular problem. Assuming that a swarm comprises *N* particles that are moving in a *D*-dimensional search space, the population position and velocity vectors are represented as ***X***∈(***x***~1~, ***x***~2~, ... ***x***~*N*~) and ***V***∈(***v***~1~, ***v***~2~, ... ***v***~*N*~), respectively. The velocity and position of the *i*th particle are described as ***x***~*i*~ = (*x*~*i*1~, *x*~*i*2~, ..., *x*~*iD*~) and ***v***~*i*~ = (*v*~*i*1~, *v*~*i*2~, ..., *v*~*iD*~) and are constrained by ***x***~*i*~ ∈ \[*x*~min~, *x*~max~\]^*D*^ and ***v***~*i*~ ∈ \[*v*~min~, v~max~\] ^*D*^, respectively. The particle moves according to the individual best solution *pBest*~*i*~ and global best solution *gBest* in each iteration. The particles of BPSO ***X*** and ***V*** were initialized by uniform random values and each particle is a candidate solution for a particular optimization problem. Each particle searches for optimized solutions according to the update formula in the topological space neighborhood in each generation.

Originally, BPSO was developed for the continuous optimization of problems; however, it has not been suitable for discrete optimization of problems. Therefore, the BPSO algorithm, which is an improved form of BPSO, was proposed for solving discrete optimization problems \[[@pone.0220719.ref031]\]. In the binary version, each particle position ***x***~*i*~ has been redefined as encoding an integer, e.g. ***x***~*i*~ ∈ {0, 1}. The position update formula is described as follows: $$v_{id} = v_{id} + c_{1}r_{1}\left( {{pBest}_{id} - x_{id}} \right) + c_{2}r_{2}\left( {{gBest}_{d} - x_{id}} \right)$$ $$if\ v_{id} \notin \left( {v_{min},v_{max}} \right)\ then\ v_{id} = {\max\left( {{\mathit{\min}\left( {v_{max},v_{id}} \right)},v_{min}} \right)}$$ $$S\left( v_{id} \right) = \frac{1}{1 + e^{- v_{id}}}$$ $$if\ \left( {S\left( v_{id} \right) > r_{3}} \right)\ then\ x_{id} = 1;else\ x_{id} = 0$$ where *d* = 1, 2, ..., *D*. *c*~1~ and *c*~2~ are the constant for acceleration coefficients. *r*~1~, *r*~2~, and *r*~3~ are the unique random values between \[0, 1\] at each iteration for each individual dimension. S () is a sigmoid function, which limits the transformation value from 0 to 1.

BPSO for gene (G×G)/environment (E×E) interaction analysis {#sec010}
----------------------------------------------------------

This section introduces a BPSO algorithm to address the SNP-SNP interaction problem. We improve the fitness function to identify the interaction between OPMD vs. normal and oral cancer vs. normal. The description is written as follows and includes the encoding schemes, fitness function, and BPSO procedure.

Encoding schemes {#sec011}
----------------

Each particle was designed to be binary-encoding and express a particular number of factor *F* combinations. The particle position is described as *x*~*i*~ = {(*F*~11~, *F*~12~), (*F*~21~, *F*~22~), ..., (*F*~*M*1~, *F*~*M*2~)}, where *M* represents the number of factors and (*F*~*m*1~, *F*~*m*2~) shows the selection of the *m*^th^ factor in the *i*^th^ particle in which *F*~*m*1~ and *F*~*m*2~ denote the expression of the particle. These two expressions are based on 0 and 1 variables; thus, four different combinations: (0, 0), (0, 1), (1, 0) and (1, 1) are included. Each particle as a candidate solution denotes the status of whole factors (selected or non-selected) and separates into three different statuses. The four different combinations are shown below: $$\left( {F_{m1},F_{m2}} \right) = \left\{ \begin{array}{l}
{\left( 0,0 \right),non - selected} \\
{\left( 0,1 \right),selected\ mth\ factor\ and\ status\ as\ 1} \\
{\left( 1,0 \right),selected\ mth\ facotr\ and\ status\ as\ 2} \\
{\left( 1,1 \right),selected\ mth\ factor\ and\ status\ as\ 3} \\
\end{array} \right.$$

Based on formula ([7](#pone.0220719.e007){ref-type="disp-formula"}), four different combinations of (*F*~*m*1~, *F*~*m*2~) can display the selection states of a factor. For instance, a particle in position *x*~*i*~ = {(0, 1), (0, 0), (1, 1), (1, 0), (0, 0)} indicates the selection state to be the 1^st^, 3^rd^, and 4^th^ factor in status 1, 3 and 2, respectively. Consequently, this expression can be used to represent multiple order interactions.

Fitness function {#sec012}
----------------

The best combination of clinical diagnoses for oral cancer and OPMD can be found as a reference to confirm the fitness function of each candidate. We utilized OR, chi-square model, and the OR difference between oral cancer vs. normal and OPMD vs. normal to identify their risk factors. The fitness function formula can be written as: $$f\left( x_{i} \right) = S\left( {OR}_{CvN} \right) + S\left( {OR}_{PvN} \right) + S\left( {{OR}_{CvN} - {OR}_{PvN}} \right) + p$$ where *S* () is the sigmoid function, which limits \[0, 1\] each weight and establishes the weight equilibrium, OR~CvN~ represents the OR value in oral cancer and normal cases, and OR~PvN~ represents OR value in OPMD and normal cases. *p* indicates the Pearson chi-squared module to assess the significance in OR~CvN~ and OR~PvN~, which is shown as formula ([9](#pone.0220719.e009){ref-type="disp-formula"}).

![](pone.0220719.e009.jpg){#pone.0220719.e009g}
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BPSO procedure {#sec013}
--------------

This study utilized BPSO to analyze interaction processes. The detailed BPSO procedure is described as follows.

Step 1) Initialize the population of particles with a uniform random position within {0, 1} and velocity within \[*v*~min~, *v*~max~\].

Step 2) Calculate the fitness of each particle using the OR value, p-value, and the OR difference according to the Eq ([8](#pone.0220719.e008){ref-type="disp-formula"}).

Step 3) Update the individual and global best solution pBest and gBest according to the fitness estimation results.

Step 4) Calculate the particle velocity and update the position of each particle according to Eqs ([3](#pone.0220719.e003){ref-type="disp-formula"})--([6](#pone.0220719.e006){ref-type="disp-formula"}).

Step 5) Repeat Steps 2--4 until the stop criterion has been met. The best combination of clinical diagnosis for risk factor of oral cancer and OPMD is consequently obtained.

Genotyping of *CYP*26 families {#sec014}
------------------------------

Peripheral blood (8 mL) was drawn from the subjects in ethylenediaminetetraacetic acid (EDTA) tubes. Using standard protocol, genomic DNA was extracted from peripheral blood lymphocytes and immediately stored at --20°C for further analysis. SNPs of *CYP26A1*, *CYP26B1*, and *CYP26C1* with minor allele frequency (MAF) were selected from a public reference Chinese HapMap database, CHB. Therefore, *CYP26A1*, *CYP26B1*, and *CYP26C1* SNPs were selected with MAF \> 10% variants from HapMap-CHB. In addition to MAF \>10%, our previous study also indicated that the variants of *CYP26A1* rs4411227 were significantly related to an increased risk of malignant oral disorders \[[@pone.0220719.ref021]\]. As mentioned above, we only selected one rs4411227 for *CYP26A1* SNP analysis in this study.

The assay of TaqMan SNP genotyping (Applied Biosystems, Foster City, CA, USA) was used to test genotypes. DNA samples and negative controls were loaded and examined in 96-well plates using the real-time polymerase chain reaction (PCR) system of ViiA™ 7 Biosystems (Applied Biosystems, Foster City, CA). Using the Sequence Detection System (SDS) 2.1 software (Applied Biosystems) fluorescence data were evaluated, and the fluorescence signals were plotted to determine the genotype of each sample.

Statistical analysis {#sec015}
--------------------

We conducted an OR-based BPSO (python algorithm program) and chi-square test to examine the association between the habits of substance use (alcohol drinking, BQ chewing, and cigarette smoking) and disease groups (OPMD, oral/ pharyngeal cancer and normal controls). Chi-square statistical analyses were performed using the SAS statistical package (version 9.1.3, SAS Institute Inc.). The application performance of SNP-environment barcodes was ascertained by receiver operating characteristic (ROC) curve and maximized Youden's index (sensitivity + specificity-- 1) was used to determine optimal cut-off points of OR scores for oral malignant disorders between low and high risk populations \[[@pone.0220719.ref032], [@pone.0220719.ref033]\].

All variables in this study were available on a public repository website (<https://github.com/kuochuanwu/SNPbarcode>) and my minimal data (filename: 190618 CYP26 SNPs-environment_risk.xlsx) set as the supplementary data, [S1 Table](#pone.0220719.s001){ref-type="supplementary-material"}.

Results {#sec016}
=======

Characterization of the study population {#sec017}
----------------------------------------

The gene structure and SNP information of *CYP26* gene families are shown in Tables [1](#pone.0220719.t001){ref-type="table"} and [2](#pone.0220719.t002){ref-type="table"}. and genetic landscape of these SNPs was described in [Fig 1](#pone.0220719.g001){ref-type="fig"}. There were no non-synonymous variants (amino acid changes) from these SNPs. In the aspect of *CYP26B1* (2p13.2), four candidate SNPs are indicated. SNP rs887844 is located in 500B downstream variant, followed by rs707718 in 3' UTR, rs3768647 in 3' UTR, and rs9309462 in intron. We selected only one SNP rs4411227 for *CYP26A1* on chromosome 10q23.33 region and rs4411227 is located in 2KB upstream variant. In the region of *CYP26C1* (10q23.33), SNP rs8211 is located in 2KB upstream and SNP rs12256889 is located in intron.

![The genetic landscapes of CYP26 SNPs.\
(A) Four candidate SNPs are indicated in genomic structure of *CYP26B1* (2p13.2). SNP rs887844 is located in 500B downstream variant, followed by rs707718 in 3' UTR, rs3768647 in 3' UTR, and rs9309462 in intron. (B) One candidate SNP is indicated in genomic structure of *CYP26A1* (10q23.33). SNP rs4411227 is located in 2KB upstream variant. (C) Two candidate SNPs are indicated in genomic structure of *CYP26C1* (10q23.33). SNP rs8211 is located in 2KB upstream and SNP rs12256889 is located in intron. Exons are denoted by black boxes.](pone.0220719.g001){#pone.0220719.g001}

10.1371/journal.pone.0220719.t001

###### CYP26 gene structure for association study of oral malignant disorders.

![](pone.0220719.t001){#pone.0220719.t001g}

  Chromosome   Gene      Region   Chromosome Position[^a^](#t001fn001){ref-type="table-fn"}   Region Length   
  ------------ --------- -------- ----------------------------------------------------------- --------------- -----
  2p13.2       CYP26B1                                                                                        
                         UTR      72,147,835                                                  72,147,862      
                         Exon     72,147,631                                                  72,147,834      204
                         Exon     72,143,989                                                  72,144,213      225
                         Exon     72,135,144                                                  72,135,419      276
                         Exon     72,134,761                                                  72,134,916      156
                         Exon     72,133,023                                                  72,133,307      285
                         Exon     72,132,227                                                  72,132,619      393
                         UTR      72,129,238                                                  72,132,226      
  10q23.33     CYP26A1                                                                                        
                         UTR      93,074,307                                                  93,074,325      
                         Exon     93,074,326                                                  93,074,532      207
                         Exon     93,074,779                                                  93,075,069      291
                         Exon     93,075,149                                                  93,075,307      159
                         Exon     93,075,826                                                  93,075,960      135
                         Exon     93,076,544                                                  93,076,696      153
                         Exon     93,076,963                                                  93,077,304      342
                         UTR      93,077,305                                                  93,077,884      
  10q23.33     CYP26C1                                                                                        
                         UTR      93,061,263                                                  93,061,263      
                         Exon     93,061,264                                                  93,061,467      204
                         Exon     93,062,010                                                  93,062,234      225
                         Exon     93,062,720                                                  93,062,995      276
                         Exon     93,064,381                                                  93,064,536      156
                         Exon     93,065,956                                                  93,066,285      330
                         Exon     93,068,320                                                  93,068,697      378
                         UTR      93,068,698                                                  93,068,697      

^a^ The data was cited from website <http://www.rcsb.org/pdb/gene/> (GRCh38)

10.1371/journal.pone.0220719.t002

###### CYP26 SNP information for association study of oral malignant disorders.

![](pone.0220719.t002){#pone.0220719.t002g}

  -----------------------------------------------------------------------------------------------------------------------------------------------
  SNP No.   Chromosome   Chromosome\                                      Gene      SNP rs No.   Location^a^               Genotype         
                         Position[^a^](#t002fn001){ref-type="table-fn"}                                                                     
  --------- ------------ ------------------------------------------------ --------- ------------ ------------------------- ---------- ----- -----
  1         2            72129066                                         CYP26B1   rs887844     500B Downstream Variant   \-         A/G   G/G

  2         2            72129320                                         CYP26B1   rs707718     3' UTR                    G/G        G/T   T/T

  3         2            72130326                                         CYP26B1   rs3768647    3' UTR                    \-         C/G   G/G

  4         2            72145857                                         CYP26B1   rs9309462    Intron Variant            \-         C/T   T/T

  5         10           93071756                                         CYP26A1   rs4411227    2KB Upstream Variant      C/C        C/G   G/G

  6         10           93059296                                         CYP26C1   rs8211       2KB Upstream Variant      C/C        C/T   T/T

  7         10           93067426                                         CYP26C1   rs12256889   Intron Variant            \-         A/C   C/C
  -----------------------------------------------------------------------------------------------------------------------------------------------

^a^ The data was cited from GRCh38.p12, National Center for Biotechnology Information (NCBI) (<https://www.ncbi.nlm.nih.gov/pubmed/>).

3' UTR, three prime untranslated region.

The demographic characteristics of and *CYP26* polymorphism in individuals with oral/pharyngeal cancers (N = 242), OPMD (N = 70) and in control subjects (N = 264) with high prevalence of BQ chewing are described in [Table 3](#pone.0220719.t003){ref-type="table"}. Five hundred and seventy-six individuals participated in our study. All male participants were over 18 years of age (mean age 48.29 ± 9.88 years). The mean age of control individuals was 44.49 ± 8.53 years, 51.01 ± 11.82 years for patients with OPMD, and 51.64 ± 9.17 years for patients with oral and pharyngeal cancer. Results demonstrated statistically significant age differences among the three groups. In terms of age, the oral and pharyngeal cancer group contained more patients (52.89%) aged over 50, which was higher than that in the controls (21.97%) significantly. Moreover, 55.71% patients with OPMD were aged over 50, which was higher than the controls group (21.97%). The percentage of individuals with low education level was 34.30% in patients with oral and pharyngeal cancers, which was significantly higher than that of the controls (22.35%). The prevalence of consuming alcohol, chewing BQ, and smoking cigarettes was not statistically significant among patients with oral/pharyngeal cancer and OPMD and the control group. According to the results of genotyping analysis, there was no deviation for all seven SNPs from the Hardy-Weinberg equilibrium in both the oral malignant disorder and control groups. The results showed that genotype frequency for *CYP26A1* (rs4411227), and *CYP26B1* (rs887844, rs3768647, and rs9309462) were significantly different among the three groups (*p* \< 0.05).

10.1371/journal.pone.0220719.t003

###### Distribution of selected demographic characteristics and the genotypes of CYP26 families among oral and pharyngeal cancers, OPMD, and controls (N = 576).

![](pone.0220719.t003){#pone.0220719.t003g}

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables                                              Oral and pharyngeal cancers (N = 242)   OPMD (N = 70)\   Controls (N = 264)\   *p*-value[^a^](#t003fn001){ref-type="table-fn"}                    
  ------------------------------------------------------ --------------------------------------- ---------------- --------------------- ------------------------------------------------- ----- ---------- ---------
  **Environment**                                                                                                                                                                                          

      Sex                                                                                                                                                                                                  

          1 male                                         232                                     (95.87)          69                    (98.57)                                           264   (100.00)   0.003

          2 female                                       10                                      (4.13)           1                     (1.43)                                            0     (0.00)     

      Age, year (mean ± SD)                              51.64 ± 9.17                            51.01 ± 11.82    44.49 ± 8.53          \<0.001[^c^](#t003fn003){ref-type="table-fn"}                      

          1 ≤ 50                                         114                                     (47.11)          31                    (44.29)                                           206   (78.03)    \<0.001

          2 \> 50                                        128                                     (52.89)          39                    (55.71)                                           58    (21.97)    

      Race                                                                                                                                                                                                 

          1 Minnan                                       202                                     (83.47)          53                    (75.71)                                           209   (79.17)    0.261

          2 Other                                        40                                      (16.53)          17                    (24.29)                                           55    (20.83)    

      Education level                                                                                                                                                                                      

          1 ≤ 6 year                                     83                                      (34.30)          21                    (30.00)                                           59    (22.35)    0.011

          2 \> 6 year                                    159                                     (65.70)          49                    (70.00)                                           205   (77.65)    

      Alcohol drinking                                                                                                                                                                                     

          0 No                                           86                                      (35.54)          25                    (35.71)                                           76    (28.79)    0.222

          1 Yes                                          156                                     (64.46)          45                    (64.29)                                           188   (71.21)    

      Betel quid chewing                                                                                                                                                                                   

          0 No                                           32                                      (13.22)          9                     (12.86)                                           44    (16.67)    0.492

          1 Yes                                          210                                     (86.78)          61                    (87.14)                                           220   (83.33)    

      Cigarette smoking                                                                                                                                                                                    

          0 No                                           28                                      (11.57)          9                     (12.86)                                           19    (7.20)     0.162

          1 Yes                                          214                                     (88.43)          61                    (87.14)                                           245   (92.80)    

  **CYP26 SNPs**[^d^](#t003fn004){ref-type="table-fn"}                                                                                                                                                     

      CYP26A1(rs4411227)                                                                                                                                                                                   

          0 C/C                                          8                                       (3.31)           3                     (4.29)                                            6     (2.27)     0.010

          1 C/G                                          81                                      (33.47)          19                    (27.14)                                           53    (20.08)    

          2 G/G                                          153                                     (63.22)          48                    (68.57)                                           205   (77.65)    

      CYP26B1 (rs887844)                                                                                                                                                                                   

          1 A/G                                          115                                     (47.52)          39                    (55.71)                                           99    (37.50)    0.008

          2 G/G                                          127                                     (52.48)          31                    (44.29)                                           165   (62.50)    

      CYP26B1 (rs707718)                                                                                                                                                                                   

          0 G/G                                          45                                      (18.60)          10                    (14.29)                                           28    (10.61)    0.161

          1 G/T                                          117                                     (48.35)          36                    (51.43)                                           139   (52.65)    

          2 T/T                                          80                                      (33.06)          24                    (34.29)                                           97    (36.74)    

      CYP26B1 (rs3768647)                                                                                                                                                                                  

          1 C/G                                          122                                     (50.41)          42                    (60.00)                                           264   (100.00)   \<0.001

          2 G/G                                          120                                     (49.59)          28                    (40.00)                                           0     (0.00)     

      CYP26B1 (rs9309462)                                                                                                                                                                                  

          1 C/T                                          17                                      (7.02)           4                     (5.71)                                            3     (1.14)     0.003

          2 T/T                                          225                                     (92.98)          66                    (94.29)                                           261   (98.86)    

      CYP26C1 (rs8211)                                                                                                                                                                                     

          0 C/C                                          159                                     (65.70)          44                    (62.86)                                           198   (75.00)    0.133

          1 C/T                                          74                                      (30.58)          23                    (32.86)                                           60    (22.73)    

          2 T/T                                          9                                       (3.72)           3                     (4.29)                                            6     (2.27)     

      CYP26C1 (rs12256889)                                                                                                                                                                                 

          1 A/C                                          234                                     (96.69)          67                    (95.71)                                           258   (97.73)    0.617

          2 C/C                                          8                                       (3.31)           3                     (4.29)                                            6     (2.27)     
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^ Significant difference was test by Chi-square analysis (*p* \< 0.05).

^b^ May not total 100% due to rounding.

^c^ Significant difference was test by general linear (GLM) model (*p* \< 0.05). SD, standard deviation.

^d^ The genotype information of case and control was partly derived from our previous work \[[@pone.0220719.ref021], [@pone.0220719.ref022]\] and variables were available at <https://github.com/kuochuanwu/SNPbarcode> ([S1 Table](#pone.0220719.s001){ref-type="supplementary-material"}).

Association between combined polymorphisms of *CYP26* and oral malignant disorders {#sec018}
----------------------------------------------------------------------------------

After considering age, gender, race, education, alcohol consumption, BQ chewing, and cigarette smoking, the joint effect (adjusted OR and 95% CI) of specific SNP combinations and environmental factors on the occurrence of oral malignant disorders were obtained ([Table 4](#pone.0220719.t004){ref-type="table"}). Specific SNP (*CYP26B1* rs887844 (A/G), *CYP26A1* rs4411227 (C/G), *CYP26C1* rs12256889 (A/C), and *CYP26B1* rs707718 (G/T)) and environmental factor (\> 50 years old) combinations significantly increased the risks (5.75-, 3.92-, 4.07-, and 3.34-fold, respectively) for patients with OPMD compared to health controls with high prevalence of BQ chewing. Patients with oral and pharyngeal cancers and specific SNP (*CYP26B1* rs887844 (A/G), *CYP26A1* rs4411227 (C/G), *CYP26C1* rs12256889 (A/C), and *CYP26B1* rs707718 (G/T)) and environmental factor (\> 50 old) combinations exhibited significantly increased risks (6.76-, 4.16-, 3.94-, and 2.80-fold, respectively) compared to health controls with high prevalence of BQ chewing. Elder subjects with rs887844 (A/G) or rs4411227 SNP (C/G) were more at risk of developing oral and pharyngeal cancers than OPMD. Inversely, elder subjects with rs12256889 (A/C), rs4411227 SNP (G/G) or rs707718 (G/T) SNPs were at lower risk of developing oral and pharyngeal cancers than OPMD. Thus, our results suggest the presence of a genome-wide cross-talk between polymorphisms of several genes and SNPs of *CYP26*, which may be involved in the occurrence of oral malignant disorders.

10.1371/journal.pone.0220719.t004

###### The top ten best risk association models of 2 factors combinations among oral and pharyngeal cancers, OPMD, and controls.

![](pone.0220719.t004){#pone.0220719.t004g}

                                    OPMD vs controls   Oral and pharyngeal cancers vs controls                                                                             
  ------------------------- ------- ------------------ ----------------------------------------- ------ --------- ------------- ----- ----- ------ --------- ------------- -------
  Age, rs887844             Other   52                 249                                                                      172   249                                  
                            2--1    18                 46                                        5.75   \<0.001   2.72--12.13   70    15    6.76   \<0.001   3.74--12.19   1.01
  Age, Race                 Other   40                 218                                                                      132   218                                  
                            2--1    30                 46                                        3.55   \<0.001   2.01--6.29    110   46    3.95   \<0.001   2.63--5.93    0.40
  Age, rs4411227            Other   59                 252                                                                      202   252                                  
                            2--1    11                 12                                        3.92   0.003     1.65--9.31    40    12    4.16   \<0.001   2.13--8.14    0.24
  Age, Alcohol drinking     Other   54                 242                                                                      186   242                                  
                            2--0    16                 22                                        3.26   0.001     1.61--6.62    56    22    3.31   \<0.001   1.95--5.62    0.05
  Age, rs12256889           Other   33                 207                                                                      116   207                                  
                            2--1    37                 57                                        4.07   \<0.001   2.34--7.08    126   57    3.94   \<0.001   2.68--5.81    -0.13
  Age, rs4411227            Other   44                 220                                                                      157   220                                  
                            2--2    26                 44                                        2.95   \<0.001   1.65--5.29    85    44    2.71   \<0.001   1.78--4.11    -0.24
  Age, Betel quid chewing   Other   39                 221                                                                      141   221                                  
                            2--1    31                 43                                        4.09   \<0.001   2.30--7.25    101   43    3.68   \<0.001   2.43--5.57    -0.41
  Age, Alcohol drinking     Other   47                 228                                                                      170   228                                  
                            2--1    23                 36                                        3.10   \<0.001   1.68--5.71    72    36    2.68   \<0.001   1.72--4.19    -0.42
  Age, rs707718             Other   49                 234                                                                      178   234                                  
                            2--1    21                 30                                        3.34   \<0.001   1.77--6.32    64    30    2.80   \<0.001   1.74--4.51    -0.54
  Age, Cigarette smoking    Other   37                 216                                                                      138   216                                  
                            2--1    33                 48                                        4.01   \<0.001   2.28--7.05    104   48    3.39   \<0.001   2.27--5.08    -0.62

^a^ The difference between oral and pharynx cancers vs control and OPMD vs control.

OR, odds ratio. 95% CI, 95% confidence interval.

Best combination model of SNP-environment with maximum risk differences between cases and controls {#sec019}
--------------------------------------------------------------------------------------------------

We used the BPSO-generated barcodes to compute the relative strength of SNP-environment combination effects on the risk of developing oral malignant disorders and determined the risk effects of subjects with oral malignant disorders who exhibited specific SNP-environment combinations or other combinations ([Table 5](#pone.0220719.t005){ref-type="table"}). After using controls (high prevalence of BQ chewing) as a reference group, we found that the elderly people within the Minnan population with SNP rs887844 (A/G) were more likely to develop oral and pharyngeal cancers (OR = 8.09) compared with OPMD (OR = 5.75). Elderly Minnan individuals who chewed BQ and harbored the SNP rs887844 (A/G) showed an elevated risk of oral and pharyngeal cancers (OR = 10.3) compared with OPMD (OR = 6.12). The maximum risks difference (oral and pharyngeal cancers versus the control groups (OR = 10.3) − OPMD versus the control group (OR = 5.42)) of 4.88 was found in elderly Minnan individuals who chewed BQ and carried the SNPs rs887844 (A/G) and rs12256889 (A/C).

10.1371/journal.pone.0220719.t005

###### Estimated joint effects on models of environmental-SNP combinations associated with oral and pharyngeal cancers, OPMD, and controls.

![](pone.0220719.t005){#pone.0220719.t005g}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                OPMD vs controls   Oral and pharyngeal cancers vs controls                                                                                                                                                                                         
  ----------------------------------------------------- ------- ------------------ ----------------------------------------- -------- ------------------------------------------- ------- ------------- ---- --------- --------- -------- ------------------------------------------- ------- ------------- ------ --
  Age,\                                                 Other   52                 (74.29)                                   249      (95.77)                                                                172       (71.07)   249      (94.32)                                                                  
  rs887844                                                                                                                                                                                                                                                                                                         

  2--1                                                  18      (25.71)            11                                        (4.23)   5.75[\*](#t005fn003){ref-type="table-fn"}   0.000   2.72--12.13   70   (28.93)   15        (5.68)   6.76[\*](#t005fn003){ref-type="table-fn"}   0.000   3.74--12.19   1.01   

  Age,\                                                 Other   56                 (80.00)                                   253      (95.83)                                                                179       (73.97)   253      (95.83)                                                                  
  Race,\                                                                                                                                                                                                                                                                                                           
  rs887844                                                                                                                                                                                                                                                                                                         

  2-1-1                                                 14      (20.00)            11                                        (4.17)   5.75[\*](#t005fn003){ref-type="table-fn"}   0.000   2.48--13.33   63   (26.03)   11        (4.17)   8.09[\*](#t005fn003){ref-type="table-fn"}   0.000   4.15--15.80   2.34   

  Age,\                                                 Other   60                 (85.71)                                   257      (97.35)                                                                189       (78.10)   257      (97.35)                                                                  
  Race,\                                                                                                                                                                                                                                                                                                           
  BQ chewing, rs887844                                                                                                                                                                                                                                                                                             

  2-1-1-1                                               10      (14.29)            7                                         (2.65)   6.12[\*](#t005fn003){ref-type="table-fn"}   0.000   2.24--16.73   53   (21.90)   7         (2.65)   10.3[\*](#t005fn003){ref-type="table-fn"}   0.000   4.58--23.15   4.18   

  Age,\                                                 Other   61                 (87.14)                                   257      (97.35)                                                                189       (78.10)   257      (97.35)                                                                  
  Race,\                                                                                                                                                                                                                                                                                                           
  BQ chewing, rs887844, rs12256889                                                                                                                                                                                                                                                                                 

  2-1-1-1-1                                             9       (12.86)            7                                         (2.65)   5.42[\*](#t005fn003){ref-type="table-fn"}   0.001   1.94--15.12   53   (21.90)   7         (2.65)   10.3[\*](#t005fn003){ref-type="table-fn"}   0.000   4.58--23.15   4.88   

  Age,\                                                 Other   62                 (88.57)                                   257      (97.35)                                                                193       (79.75)   257      (97.35)                                                                  
  Race,\                                                                                                                                                                                                                                                                                                           
  BQ chewing, Cigarette smoking, rs887844, rs12256889                                                                                                                                                                                                                                                              

  2-1-1-1-1-1                                           8       (11.43)            7                                         (2.65)   4.74[\*](#t005fn003){ref-type="table-fn"}   0.005   1.66--13.56   49   (20.25)   7         (2.65)   9.32[\*](#t005fn003){ref-type="table-fn"}   0.000   4.13--21.03   4.58   
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^ The risk difference between oral and pharynx cancers vs controls and OPMD vs controls.

OR, odds ratio. 95% CI, 95% confidence interval.

\* An OR value ≥ 2.39 indicates high risk with oral malignant disorders.

In the risks assessment, the odds ratio (OR) was used to evaluate the impact of risk association of SNP-environment combinations for oral malignant disorders between high and low risk populations. We used ROC curve to predict the discriminatory power of OR risks of SNP-environment barcodes for population with oral malignant disorders ([Fig 2](#pone.0220719.g002){ref-type="fig"}). A significant application performance (area under the curve (AUC) = 0.755; 95% confidence interval (CI) = 0.750--0.760; *p*\<0.001) of SNP-environment barcodes for oral malignant disorders was found by ROC curve. Maximized Youden's index was used to determine optimal cut-off points of OR scores for predicting high risk population with oral malignant disorders. Optimal sensitivity (91%) for predicting high risk population was achieved with a OR cut-off of greater than or equal to 2.39. Indeed, we provided the best discrimination of OR \< 2.39 and OR ≥ 2.39 for oral malignant disorders between low and high risk populations.

![Receiver operating characteristic (ROC) curve analysis of the OR risks of SNP-environment combinations for population with oral malignant disorders.\
The area under the curve (AUC) = 0.755 (95% confidence interval (CI) = 0.750--0.760; *p*\<0.001) was used to discriminate OR *\<* 2.39 from OR ≥ 2.39 for low and high risk populations with oral malignant disorders.](pone.0220719.g002){#pone.0220719.g002}

Discussion {#sec020}
==========

The occurrence of cancers was implicated in the combined effects between genes and environment, but confirming joint effects was a computational and mathematical challenge. In terms of multiple SNPs, genome-wide association studies (GWAS) have been indicated commonly to discover the associative effects of diseases \[[@pone.0220719.ref034]--[@pone.0220719.ref039]\]. A number of GWAS \[[@pone.0220719.ref040]--[@pone.0220719.ref042]\] and non-GWAS \[[@pone.0220719.ref043], [@pone.0220719.ref044]\] studies have recognized the interaction of SNPs. Nevertheless, the association effects based on SNP-SNP interaction between *CYP* families SNPs and the risk associations in oral malignant disorders are less frequently mentioned. In terms of the computational biological challenge, potential and substantial associations are often hidden in the large number of possible combined effects on numerous SNPs genotypes. A number of studies have indicated computational approaches to ameliorate the effects of association of multiple SNPs analysis \[[@pone.0220719.ref045]--[@pone.0220719.ref049]\]. Nevertheless, these strategies have been confronted with computational intensity as the number of SNPs increases \[[@pone.0220719.ref050]\]. Major issues arise from this challenge, along with calculating SNP-SNP relationships in terms of combinations of SNPs corresponding to genotypes and SNPs combined with environmental factors.

The approaches of conventional statistics, machine learning, and data mining have been established to evaluate potential effects in GWAS association studies \[[@pone.0220719.ref024], [@pone.0220719.ref025], [@pone.0220719.ref051]--[@pone.0220719.ref056]\]. Therefore, mathematical optimization algorithm of the OR-based method was applied to examine the susceptible risks of several cancers and disorders \[[@pone.0220719.ref023], [@pone.0220719.ref027], [@pone.0220719.ref028], [@pone.0220719.ref053], [@pone.0220719.ref055], [@pone.0220719.ref057]--[@pone.0220719.ref059]\]. The strength of BPSO was used to ascertain the simulation-based association models with rapid and easy statistically analysis.

Epidemiological studies indicated that OPMD and oral/pharyngeal cancers have a close relationship with environmental exposure to BQ, alcohol, and cigarettes, particularly in heavy BQ users \[[@pone.0220719.ref007], [@pone.0220719.ref008], [@pone.0220719.ref022], [@pone.0220719.ref060]--[@pone.0220719.ref062]\]. In 2004, IARC indicated that the areca nut and chewable BQ, particularly those without tobacco, comprised group 1 human carcinogens of the oral cavity \[[@pone.0220719.ref009]\]. In Taiwan, the 2016 cancer report indicated that oral cavity and pharyngeal cancers were the fourth most prevalent cancers with an incidence rate of 42.43 per 100,000 individuals among males \[[@pone.0220719.ref063]\]. In addition, it ranked as the fourth leading cause of death due to cancer, and the mortality rate was 15.71 per 100,000 individuals \[[@pone.0220719.ref063]\].

BQ alkaloids, arecoline and arecaidine can cause bacterial mutagenicity, and in mammalian cells, *in vivo* or *in vitro* tests can result in sister chromatographic exchange, chromosomal aberrations, and micronuclei formation \[[@pone.0220719.ref009]\]. In addition to the areca nut extract, arecoline also induces the dysregulation of oral epithelial cells, leading to cell cycle arrest \[[@pone.0220719.ref064]\]. We previously reported that arecoline (a major alkaloid in BQ) significantly induced *CYP26B1* expression \[[@pone.0220719.ref065]\]. *CYP26* has three isoforms---namely, *CYP26A1*, *CYP26B1*, and *CYP26C1*---which mainly metabolize retinoic acid (RA)-related compounds \[[@pone.0220719.ref066]\]. RA is a biologically active derivative of vitamin A, which regulates growth, differentiation, and apoptosis of several cell types, and plays an important role in visual physiological function, embryonic development patterns, and adult physiological mechanisms \[[@pone.0220719.ref067], [@pone.0220719.ref068]\].

The risk of developing oral malignant disorders may be related to the functionally relevant combined effects of SNPs such as those in *CYP26A1*, *CYP26B1*, and *CYP26C1* within and between different cancer pathways. Since interactions among multiple genes influenced the risk component of oral and pharyngeal cancers, our rationale for identifying interactions between genes was justified. We developed new and feasible analytical methods to systematically examine the interactions between genome-wide SNPs and various environmental factors. In particular, we investigated the role of combinational SNPs in three metabolism-related genes (*CYP26A1*, *CYP26B1*, and *CYP26C1*) in oral malignant disorders. In association studies of disease predisposition, the interaction analyses of SNPs increased the performance \[[@pone.0220719.ref019], [@pone.0220719.ref028], [@pone.0220719.ref058], [@pone.0220719.ref069]--[@pone.0220719.ref071]\].

In oral and pharyngeal cancers and OPMD disorders, we also explored the risk factors for genetic variation of complex traits. We hypothesized that two important SNPs (*CYP26B1* rs887844 and *CYP26C1* rs12256889) within *CYP26* may significantly elevate genetic susceptibility to oral and pharyngeal cancers and OPMD. The association between the risk of developing oral/pharyngeal cancers and OPMD and *CYP26* SNPs was detected by a robust BPSO algorithm combined with statistical analysis. The BPSO algorithm optimally evaluated the risk effects of *CYP26* SNPs for oral and pharyngeal cancers and OPMD. Complex multifactor associations are difficult to analyze statistically \[[@pone.0220719.ref072]\]. Accordingly, comprehensive approaches to evaluate the best association models with disorder-related factors were used in several studies \[[@pone.0220719.ref054], [@pone.0220719.ref056], [@pone.0220719.ref073], [@pone.0220719.ref074]\], and these methods have suitable power to test the potential model of associations.

SNPs and environmental factor combinations were calculated using the BPSO method, and their relationships with disease risk were examined by selecting prominent SNPs. Indeed, this algorithm assisted in comprehensively recognizing the genetic basis of complex diseases/traits. Our published study presented that *CYP26* is a candidate gene family for assessing the risks of occurrence of oral/pharyngeal cancers and OPMD \[[@pone.0220719.ref010], [@pone.0220719.ref021], [@pone.0220719.ref022]\], and specific SNP combinations of *CYP26* may be associated with increased risk of developing oral/pharyngeal cancers and OPMD. Nevertheless, the joint effects of *CYP26* SNP-environmental factor combinations on the risk of developing oral malignant disorders were not examined previously using SNP-environmental factors interaction methods.

In this study, we revealed a strong correlation between *CYP26* SNP-environmental factor interaction (old age, Minnan ethnicity, BQ chewers, and smoking) and the risk of oral malignant disorder occurrence. Two significant *CYP26* SNPs (*CYP26B1* rs887844 (A/G) and *CYP26C1* rs12256889 (A/C)) were selected using BPSO analysis, which was the best performance model for oral malignant disorder occurrence risk analysis. The analysis suggested that several combinations of environmental factors and candidate SNPs had the highest risk for susceptibility to oral malignant disorders. The risks were more prominent in the oral and pharyngeal cancers group (OR = 10.30; 95% CI = 4.58--23.15) than in the OPMD group (OR = 5.42; 95% CI = 1.94--15.12). This finding implies that older individuals with SNP rs887844 and rs12256889 of Minnan ethnicity who chewed BQ were more likely to suffer from oral and pharyngeal cancers than from OPMD.

In this study, we conducted a powerful binary particle swarm optimization (BPSO) of an odds ratio (OR)-based method to evaluate the joint effect of gene-gene-environment (SNP-SNP-environment) in oral malignant disorders. The BPSO-based SNP-SNP and SNP-environment interactions were not limited to SNPs on the same chromosome, and our algorithm could control potential confounders and diverse numbers of SNP. Moreover, the BPSO approach calculated the best performance of the SNP or SNP-environment model with the risk of maximum difference between cases and control groups. The ROC curve was used to discriminate OR risks of SNP-environment barcodes for oral malignant disorders as shown in [Fig 2](#pone.0220719.g002){ref-type="fig"}. Certainly, the best cutoff points of OR \< 2.39 and OR ≥ 2.39 were provided for oral malignant disorders between low and high risk populations. The idea of simulation-based CYP26 SNP-environment barcodes and barcode concepts for population with oral malignant disorders were presented in schematic diagram ([Fig 3](#pone.0220719.g003){ref-type="fig"}). Our SNP-environment data can be converted to create barcodes to distinguish between the low and high risk group (e.g., 2--1, and 2-1-1-1-1-1) of oral malignant disorders.

![Application of simulation-based novel SNP-environment barcodes for evaluating the occurrence of oral malignant disorders by odds ratio-based BPSO.\
(A) After calculating and analysis statistically by BPSO, we render combined associations of each high-risk group from SNP-environment data. (B) SNP-environment data can be converted to create barcodes (e.g., 2--1, 2-1-1-1-1, and 2-1-1-1-1-1) from each subject and render them prone to the low and high risk group of oral malignant disorders. ICONs are designed by Freepik (<https://www.freepik.com/>).](pone.0220719.g003){#pone.0220719.g003}

Study limitations {#sec021}
-----------------

Although we are do not create a barcode system for evaluating the risks of occurrence of oral malignant disorders, the term "barcodes" has been applied in a number of our published papers \[[@pone.0220719.ref023]--[@pone.0220719.ref028]\]. Owing to the difficulty of the statistical analyses in evaluating complex multifactor associations (particularly gene jointed with environment factors), we render the OR-based BPSO method to generate SNP-environment barcodes as a simulation proxy of barcodes to predict the risks of oral malignant diseases susceptibility.

After calculations and a statistical analysis using BPSO approach, and we render combined associations of each high-risk group from SNP-environment data ([Table 5](#pone.0220719.t005){ref-type="table"}). We clarified the proposed concept of SNP-environment barcodes as shown in [Fig 3](#pone.0220719.g003){ref-type="fig"}. SNP-environment data can be converted to create SNP-environment barcodes from each subject and render them prone to the high risk group (OR ≥ 2.39) of oral malignant disorders.

Conclusions {#sec022}
===========

We demonstrated the significant joint effects of *CYP26* SNPs and environmental factors on the risk of oral malignant disorder occurrence by BPSO method for the first time. Therefore, the BPSO-based SNP-SNP and SNP-environment approaches for assessing the combined effects of the novel SNP-environment approach may potentially assist in identifying complex biological relationships among cancer processes during the development of oral malignant disorders.

In summary, the combined effects of the novel *CYP26* SNP-environment approach may predict the risk of occurrence of oral malignant disorders. Its application as a proxy of SNP-environment barcodes will provide insights into the importance of establishing screening tests for BQ chewers to promote the prevention of oral malignant disorders.

Supporting information {#sec023}
======================

###### Supplementary data (190618 CYP26 SNPs-environment_risk).

(XLSX)
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Click here for additional data file.
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